Analysts/Institutional Investor Meet/Con. Call Updates Goldiam International Limited has informed the Exchange about Transcript Goldiam International Limited has informed the Exchange about Transcript
Analysts/Institutional Investor Meet/Con. Call Updates Goldiam International Limited has informed the Exchange about Transcript Goldiam International Limited has informed the Exchange about Transcript
Result Please find attached Financial Results for the quarter and year ended on March 31, 2026 as approved by the Board of Directors of the Company. Please find attached Financial Results for the quarter and year ended on March 31, 2026 as approved by the Board of Directors of the Company.
Result Please find attached Financial Results for the quarter and year ended on March 31, 2026 as approved by the Board of Directors of the Company. Please find attached Financial Results for the quarter and year ended on March 31, 2026 as approved by the Board of Directors of the Company.
Company Update In continuation of our letter dated May 22 & 27, 2026 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a transcript of the Earnings Call held on May 27, 2026 on Audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31, 2026. In continuation of our letter dated May 22 & 27, 2026 and pursuant to Regulation 30(6) of the SEBI (Listing Obligation
Company Update In continuation of our letter dated May 22 & 27, 2026 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a transcript of the Earnings Call held on May 27, 2026 on Audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31, 2026. In continuation of our letter dated May 22 & 27, 2026 and pursuant to Regulation 30(6) of the SEBI (Listing Obligation
Outcome of Board Meeting Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Outcome of Board Meeting Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Company Update We submit herewith Annual Secretarial Compliance Report for the FY 2025-26. We submit herewith Annual Secretarial Compliance Report for the FY 2025-26.
Company Update We submit herewith Annual Secretarial Compliance Report for the FY 2025-26. We submit herewith Annual Secretarial Compliance Report for the FY 2025-26.
Outcome of Board Meeting HandsOn Global Management (HGM) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026 and other matters. HandsOn Global Management (HGM) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026 and other matters.
Outcome of Board Meeting HandsOn Global Management (HGM) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026 and other matters. HandsOn Global Management (HGM) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026 and other matters.
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.